During the past decade, Neuro-Medic Janusz Zbrojkiewicz conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neuro-Medic Janusz Zbrojkiewicz" are "Agitation" (1 trials), "Alzheimer's Type Dementia" (1 trials), "Multiple Sclerosis (MS)" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Neuro-Medic Janusz Zbrojkiewicz" in a lesser frequency.

Most popular intervention types in "Neuro-Medic Janusz Zbrojkiewicz" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Nabiximols" (2 trials), "IMU-838 tablets" (1 trials), "Masupirdine 100 mg" (1 trials) and "Masupirdine 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuro-Medic Janusz Zbrojkiewicz" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Neuro-Medic Janusz Zbrojkiewicz". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Neuro-Medic Janusz Zbrojkiewicz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neuro-Medic Janusz Zbrojkiewicz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".